血清3项指标联合检测对肝硬化患者的早期诊断价值  

The diagnosis value of the combined detection on three serum indicators of patients with liver cirrhosis

作　　者：唐满玲 胡卫[1] 彭俊[1] 

机构地区：[1]湖南省株洲市一医院检验科,412000

出　　处：《检验医学与临床》2011年第19期2310-2310,2314,共2页Laboratory Medicine and Clinic

摘　　要：目的探讨血清结合珠蛋白(HP)、前清蛋白(PA)和视黄醇结合蛋白(RBP)联合检测对肝硬化患者早期诊断的临床意义。方法采用免疫比浊法分别检测65例肝硬化患者和80例健康成年人血清HP、PA和RBP的水平,并进行相关统计分析。结果肝硬化患者HP、PA、RBP水平均显著低于健康对照组(P<0.01)。结论血清HP、PA、RBP水平与肝功能损害程度密切相关,三者联合检测对肝硬化患者的早期诊断具有良好的临床参考价值。Objective To investigate clinical significance of combined detection on the serum HP,PA and RBP in early diagnosis of patients with liver cirrhosis.Methods The serum HP,PA and RBP of 65 patients and 80 healthy adults were detected respectively by immune turbidimetry,and results were analyzed.Results The levels of HP,PA and RBP from patients with liver cirrhosis were lower than those of the normal control group（P0.01）.Conclusion Serum levels of HP,PA and RBP are closely related to liver damage degree,and combined detection has a good clinical value on early diagnosis of patients with liver cirrhosis.

关 键 词：肝硬化 结合珠蛋白 前清蛋白 视黄醇结合蛋白 

分 类 号：R392.7[医药卫生—免疫学]